Myriad Genetics (MYGN) Tops Q1 EPS by 3c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $5.91 -6.93%
Financial Fact:
Income tax provision (benefit): 5.2M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Income tax provision (benefit): 5.2M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q1 EPS of ($0.03), $0.03 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $195.9 million versus the consensus estimate of $200.9 million.
GUIDANCE:
Myriad Genetics sees FY2025 EPS of ($0.02)-$0.02, versus the consensus of $0.08. Myriad Genetics sees FY2025 revenue of $807-823 million, versus the consensus of $916 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loews Corp. (L) Reports Q3 EPS of $1.50
- 360 Finance, Inc. (QFIN) 2K contracts of January 2029 7.5 calls as share price up 3.7%
- Interactive Brokers reports October 2026 brokerage metrics
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
